At a glance
- Originator Novartis
- Class Antihypertensives
- Mechanism of Action ACE inhibitors; Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension; Kidney disorders
Most Recent Events
- 08 Oct 2001 No-Development-Reported for Hypertension in USA (PO)
- 08 Oct 2001 No-Development-Reported for Kidney disorders in USA (PO)
- 22 May 2001 Profile reviewed but no significant changes made